
BLUE BIOFUELS, INC.
90
Recent news coverage includes general market and sector developments but no direct company-specific operational updates.
- Blue Biofuels completed pilot plant build-out and process optimization by 2023 and finalized upscaling and testing by 2025 to prepare for commercial scale design and cost estimates [S1].
- The company formed a 50-50 joint venture with Vertimass in January 2024 to build an ethanol-to-SAF facility in Florida targeting initial production of 10-25 million gallons of sustainable aviation fuel [S1].
- As of September 30, 2026, Blue Biofuels reported cash and equivalents of $6,473, current assets of $18,524, current liabilities of $3,677,961, a net loss of $1,385,268, and EPS of -$0.004 [S2].
- The company plans to leverage renewable fuel credits including D3 and D7 RINs, Clean Fuel Production Credits, and Low Carbon Fuel Standard Credits to enhance profitability [S1].
Blue Biofuels, Inc. was incorporated in 2012 and focuses on emerging technologies in renewable energy, specifically biofuels derived from cellulosic materials. The company developed and patented a continuous mechanical/chemical Cellulose-to-Sugar (CTS) process that breaks down various cellulosic feedstocks, including grasses and agricultural waste, into fermentable sugars for biofuel production. This technology offers higher yields and lower feedstock costs compared to traditional corn ethanol. Blue Biofuels completed a pilot plant and optimized its process by 2023, with further upscaling and testing completed by 2025 to finalize commercial plant design and cost estimates. The company licensed the Vertimass Process to convert ethanol into sustainable aviation fuel (SAF) and other biofuels and formed a joint venture, VertiBlue Fuels, LLC, to build an ethanol-to-SAF facility in Florida. The business model includes leveraging renewable fuel credits such as D3 and D7 RINs, Clean Fuel Production Credits, and Low Carbon Fuel Standard Credits. The company has not yet generated material revenues and faces regulatory and financing challenges to commercialize its technology [S1].
Blue Biofuels, Inc. is a technology company specializing in renewable energy and biofuels, with patented Cellulose-to-Sugar (CTS) technology enabling conversion of cellulosic feedstock into biofuels. The company has developed a pilot plant and formed a joint venture to produce sustainable aviation fuel (SAF). Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. As of September 30, 2026, the company reported cash and equivalents of $6,473, current assets of $18,524, current liabilities of $3,677,961, a net loss of $1,385,268, and EPS of -$0.004 [S1][S2].
The company has developed a patented, scalable technology for converting cellulosic feedstocks into biofuels with higher yields and lower feedstock costs than corn ethanol. Its pilot plant and joint venture with Vertimass demonstrate progress toward commercial production of sustainable aviation fuel and other biofuels. The business model targets valuable renewable fuel credits and government incentives, which could enhance profitability once commercial operations commence. The company's intellectual property portfolio and strategic partnerships provide a foundation for growth and potential licensing opportunities [S1].
Blue Biofuels has not yet generated material revenues and reported a net loss and negative earnings per share in the latest quarter. The company faces significant liquidity challenges, with current liabilities vastly exceeding current assets and cash reserves, resulting in a very low current ratio and cash ratio. Commercialization depends on securing project financing and regulatory approvals, which require substantial capital and resources. The competitive ethanol industry and regulatory uncertainties pose risks to execution and profitability. The company's small employee base may limit operational capacity [S1][S2].
Blue Biofuels' moat is based on its patented CTS technology that enables efficient conversion of diverse cellulosic feedstocks into fermentable sugars, offering higher yields and lower costs than corn ethanol. The company holds multiple patents granted in the US and other jurisdictions and has filed additional patents internationally. Its licensing of the Vertimass Process for ethanol-to-SAF conversion and the formation of a joint venture to build production facilities further strengthen its position. The combination of proprietary technology, intellectual property, and strategic partnerships creates barriers to entry for competitors in the cellulosic biofuels market [S1].
• Liquidity Risk: The company has a current ratio of 0.01 and cash ratio of 0 as of September 30, 2026, indicating limited liquidity to meet short-term obligations.
• Execution Risk: Commercial production depends on securing project financing, regulatory approvals, and successful scale-up of technology from pilot to commercial scale.
• Regulatory Risk: Renewable fuels production requires compliance with EPA and state regulations, including premarket approvals and ongoing compliance costs.
• Market Competition: The ethanol industry is competitive with over 200 plants in the US, mostly using corn feedstock; Blue Biofuels must compete with established producers.
Business trends: Development of cellulosic biofuel technology and formation of joint ventures to produce sustainable aviation fuel.
Execution milestones: Completion of pilot plant, process optimization, and securing project financing and regulatory approvals for commercial plants.
Key risks: Liquidity constraints, regulatory compliance, competitive ethanol market, and successful scale-up from pilot to commercial production.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Blue Biofuels, Inc. is a technology company focused on renewable energy, biofuels, and lignin since 2013.
- The company developed a patented Cellulose-to-Sugar (CTS) reactor technology with higher yield and continuous throughput, patented in the US and other jurisdictions.
- CTS is a continuous mechanical/chemical process that breaks down cellulosic material including grasses and agricultural waste into fermentable sugars.
- The company completed a pilot plant build-out and process optimization by 2023 and finalized upscaling and testing by 2025 to prepare for commercial scale design and cost estimates.
- Blue Biofuels licensed the Vertimass Process, a patented one-step process converting ethanol into sustainable aviation fuel (SAF) and other renewable biofuels.
- In January 2024, Blue Biofuels formed a 50-50 joint venture with Vertimass called VertiBlue Fuels, LLC, aiming to build an ethanol-to-SAF facility in Florida with initial production goals of 10-25 million gallons of SAF.
- The company plans to switch from sugarcane ethanol to cellulosic ethanol once its CTS technology factory is operational.
- The business model involves producing cellulosic biofuels with higher yields and lower feedstock costs compared to corn ethanol, targeting renewable fuel credits such as D3 and D7 RINs, Clean Fuel Production Credits, and Low Carbon Fuel Standard Credits.
- Blue Biofuels has not generated material revenues as of the latest filings.
- The company filed for Chapter 11 bankruptcy in 2018 and exited in 2019 unimpaired.
- As of September 30, 2026, the company had cash and equivalents of $6,473 and current assets of $18,524 but current liabilities of $3,677,961, resulting in a current ratio of 0.01 and a cash ratio of 0, indicating liquidity challenges.
- The company reported a net loss of $1,385,268 and basic and diluted EPS of -$0.004 for the quarter ended September 30, 2026.
- Blue Biofuels is authorized to issue up to 1 billion shares of common stock and 10 million shares of preferred stock.
- The company employs six full-time employees, one part-time employee, and four consultants, with plans to hire more for commercialization.
- Renewable fuels production is subject to regulatory approvals and compliance, including EPA and state regulations, which require resources and capital.
- The company plans to raise capital through project-based financing to build commercial plants and comply with regulatory requirements.
Generated 2026-11-13
- S1 | 2026-03-19 | 10-K
- S2 | 2026-11-13 | 10-Q
- N1 | 2026-11-13 | www.nasdaq.com | Stocks Settle Lower on Nvidia Rout and Higher Crude and Bond Yields | https://www.nasdaq.com/articles/stocks-settle-lower-nvidia-rout-and-higher-crude-and-bond-yields
- N2 | 2026-11-13 | www.nasdaq.com | Zealand Pharma Wins EU Approval For Zeydovio To Treat Short Bowel Syndrome | https://www.nasdaq.com/articles/zealand-pharma-wins-eu-approval-zeydovio-treat-short-bowel-syndrome
- N3 | 2026-11-13 | www.nasdaq.com | 3 Dividend Stocks That Raised Their Payouts Through Both 2008 and 2020 | https://www.nasdaq.com/articles/3-dividend-stocks-raised-their-payouts-through-both-2008-and-2020
- N4 | 2026-11-13 | www.nasdaq.com | Snail Inc (SNAL) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/snail-inc-snal-q3-2026-earnings-call-transcript
- N5 | 2026-11-13 | www.nasdaq.com | PEDEVCO (PED) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/pedevco-ped-q3-2026-earnings-call-transcript
- N6 | 2026-11-13 | www.nasdaq.com | Verrica (VRCA) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/verrica-vrca-q3-2026-earnings-call-transcript
- N7 | 2026-11-13 | www.nasdaq.com | INNOVATE (VATE) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/innovate-vate-q3-2026-earnings-call-transcript
- N8 | 2026-11-13 | www.nasdaq.com | NeoVolta (NEOV) Q1 2027 Earnings Call Transcript | https://www.nasdaq.com/articles/neovolta-neov-q1-2027-earnings-call-transcript
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


